Novocure Ltd (NVCR)

Novocure Ltd (NVCR) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.8B; returns 1 day -2.8%, 1 week +4.3%, 1 year +5.5%.

Novocure Ltd. (NVCR) is a global oncology company focused on developing and commercializing Tumor Treating Fields (TTFields) therapy, a novel, non-invasive cancer treatment that uses alternating electric fields to disrupt cancer cell division.

Groups NVCR belongs to

• Oncology
• Cancer Therapeutics
• Medical Devices
• Healthcare
• Healthcare Technology
• Commercial Stage Biotech
• Biotechnology
• Life Sciences
• Clinical Stage
• Wearable Technology

NVCR financial model: income statement, cash flow and balance sheet